Earth Biosciences

Earth Biosciences is a Cambridge-based biotechnology company focused on discovering novel small molecule therapeutics by mining the Earth's microbiome. The company utilizes a proprietary platform that combines metagenomics, synthetic biology, and high-throughput screening to identify and express biosynthetic gene clusters (BGCs) from environmental samples. By accessing the "dark matter" of microbial chemistry, Earth Biosciences aims to develop first-in-class medicines for challenging targets in oncology, immunology, and infectious diseases. Their approach revitalizes natural product discovery through modern genomic and computational tools, allowing for the systematic exploration of chemical space that was previously inaccessible.